nav-left cat-right
cat-right

Theravance Announces Initiation of Phase 1 Clinica...

Theravance, Inc. (NASDAQ: THRX) today announced that GlaxoSmithKline plc (GSK) initiated subject screening in a Phase 1 clinical study designed to assess the safety, tolerability, and pharmacokinetics of an investigational, inhaled bronchodilator, GSK1160724, for the treatment of chronic obstructive pulmonary disease (COPD). The compound was discovered by Theravance and is being developed by GSK under the parties’...

Genoway launches standardized genetically modified...

The biotechnology company continues its strong growth (+50% tendency) and reinforces its international leadership in the development and supply of genetically modified animal models. The products henceforth available from the catalogue have already attracted Pfizer, GSK, BMS and Servier. Lyon (France), 19 November 2007 – genOway, a biotechnology company specialized in the development of genetically modified research...

Antidepressant Found To Extend Lifespan In C. Eleg...

ScienceDaily (Nov. 22, 2007) — A team of scientists led by Howard Hughes Medical Institute (HHMI) investigator Linda B. Buck has found that a drug used to treat depression can extend the lifespan of adult roundworms. Buck and colleagues Michael Petrascheck and Xiaolan Ye report in the November 22, 2007, issue of the journal Nature, that the antidepressant drug mianserin can extend the lifespan of the nematode...

Device Offers Pharmaceutical Makers A Fast, Cheap ...

A new device invented by researchers at the University of Virginia could save pharmaceutical companies significant time and money in screening potential new drug compounds. “We want to help the pharmaceutical industry identify effective therapuetic compounds by allowing them to fail early, fail fast, and fail cheap before going to very expensive animal studies,” said Brett Blackman, an assistant professor in...

New Database Screening Criteria Improves Identific...

Scientists in Indiana and Michigan have developed a better way of mining a vast computerized database for chemical nuggets that could become tomorrow’s cancer medications. The new “data mining” method pinpoints chemical structures with drug-like activity. It could speed the identification and development of new, more effective drugs against breast, prostate, lung and other cancers. Computers have become a...

Magellan BioScience Group, Inc. and the University...

Tampa, FL – Magellan BioScience Group, Inc. (Magellan), a pioneer in innovative drug discovery and development from marine microbial sources, and the University of Medicine and Dentistry of New Jersey (UMDNJ) announced today that they have entered into an anti-leukemia drug discovery collaboration. Magellan will team with UMDNJ scientist Dr. Scott Kachlany. This collaboration will bring together Magellan’s...
Page 30 of 40« First...1020...2829303132...40...Last »